APA (7th ed.) Citation

Everts‐Graber, J., Burkhard, J., Schaller, B., Reichenbach, S., & Lehmann, T. (2022). Reply to Potential Issues With the Use of Teriparatide After Denosumab‐Related Osteonecrosis of the Jaw. Journal of Bone & Mineral Research, 37(10), 2046. https://doi.org/10.1002/jbmr.4656

Chicago Style (17th ed.) Citation

Everts‐Graber, Judith, John‐Patrik Burkhard, Benoît Schaller, Stephan Reichenbach, and Thomas Lehmann. "Reply to Potential Issues With the Use of Teriparatide After Denosumab‐Related Osteonecrosis of the Jaw." Journal of Bone & Mineral Research 37, no. 10 (2022): 2046. https://doi.org/10.1002/jbmr.4656.

MLA (9th ed.) Citation

Everts‐Graber, Judith, et al. "Reply to Potential Issues With the Use of Teriparatide After Denosumab‐Related Osteonecrosis of the Jaw." Journal of Bone & Mineral Research, vol. 37, no. 10, 2022, p. 2046, https://doi.org/10.1002/jbmr.4656.